Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial-Reference-Cited by-同舟云学术

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Published:2016-06 Issue:6 Volume:16 Page:685-697
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Manns Michael,Samuel Didier,Gane Edward J,Mutimer David,McCaughan Geoff,Buti Maria,Prieto Martín,Calleja José Luis,Peck-Radosavljevic Markus,Müllhaupt Beat,Agarwal Kosh,Angus Peter,Yoshida Eric M,Colombo Massimo,Rizzetto Mario,Dvory-Sobol Hadas,Denning Jill,Arterburn Sarah,Pang Phillip S,Brainard Diana,McHutchison John G,Dufour Jean-François,Van Vlierberghe Hans,van Hoek Bart,Forns Xavier

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference13 articles.

1. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;van der Meer;JAMA,2012

2. The natural history of hepatitis C cirrhosis after liver transplantation;Firpi;Liver Transpl,2009

3. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study;Curry;Gastroenterology,2015

4. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation;Charlton;Gastroenterology,2015

5. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation;Forns;Hepatology,2015

Cited by 402 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Liver Transplant Eligibility in Chronic Liver Disease Patients: A Cross-Sectional Study From a Tertiary Care Hospital of Pakistan;Cureus;2024-05-24

2. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review;Medicina;2024-04-24

3. Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis;Digestive Diseases and Sciences;2024-04-05

4. Personalized care approaches to hepatitis C therapy: recent advances and future directions;Expert Review of Anti-infective Therapy;2024-03-11

5. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03